Tarver says clinical trial diversity action plans are a marketing opportunity
Regulatory NewsFerdous Al-Faruque
CDRHDiagnostics/IVDsDiversityMedical DevicesRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueCDRHDiagnostics/IVDsDiversityMedical DevicesRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)